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ABSTRACT 16 
Attine ants use antimicrobials produced by commensal bacteria to inhibit parasites on their 17 
fungal gardens. However, in this agricultural system, antimicrobial use does not lead to 18 
overwhelming resistance, as is typical in clinical settings.  Mixtures of continually-evolving 19 
antimicrobial variants could support this dynamic. 20 
 21 
 22 
Symbiotic antiparasite defence strategies. 23 
In an antimicrobial-mediated evolutionary arms race, the synthesis and release of 24 
antimicrobials evolves in one group of organisms and their competitor organisms counter this 25 
2 
 
by evolving antimicrobial resistance. Within such a milieu of intense selection and counter-26 
selection, not only will participating organisms evolve, but so too will the antimicrobials 27 
themselves.  28 
 29 
Fungus-growing ants (tribe: Attini) have cultivated specific fungi as food for 60 million years 30 
[1]. Their co-evolutionary interdependence is so refined that, for many attine species, their 31 
fungal cultivars are not found outside this symbiotic association [1, 2]. The fungi need 32 
specific microclimates and nutrition provided by the ants and, in turn, constitute the ants’ sole 33 
food source. Other fungi, of the genus Escovopsis, can invade the cultivated fungus and, 34 
because the ants rely entirely on cultivated fungus for food, this parasitism is detrimental to 35 
the ants  [2]. To counteract these parasitic fungi, ants have evolved multiple strategies.  One 36 
is a tripartite mutualistic relationship, within which the ants host antimicrobial-producing 37 
bacteria on their bodies to protect their fungal cultivar. Many of these bacteria have 38 
coevolved with their hosts, producing antimicrobials to inhibit the parasitic fungi whilst in 39 
return the ants provide them with nutrition and a microclimate suitable for growth [3]. The 40 
parasitic fungi compete with the ant-associated bacteria, as both depend upon the same 41 
fundamental source from which they directly, or indirectly, derive nutrition (BOX 1).  42 
Thus, a question arises: Why are these antimicrobials still effective in controlling the parasitic 43 
fungi even after millions of years, whilst pharmaceutical antimicrobials are rendered 44 
ineffective within a few decades? 45 
  46 
Antimicrobial heterogeneity through the evolution of gene clusters.  47 
To control the parasitic Escovopsis, the ants house antimicrobial-producing strains of 48 
Pseudonocardia and Streptomyces bacteria on their cuticle.  Streptomyces strains inhabiting 49 
attine clades are acquired via environmental sampling and are, thus, not associated with 50 
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specific taxa, but the Pseudonocardia are non-randomly associated with attine species and 51 
display co-speciation at higher taxonomic levels [4]. Ant-associated Streptomyces produce 52 
the antimicrobials candicidin and antimycin [5 and references within]. Variants of antimycin 53 
produced by Streptomyces differ in ultraviolet absorbance profile, liquid chromatography 54 
retention time and mass-to-charge (m/z) ratio [5], and are produced by 14 gene clusters 55 
(ranging from 15 to 17 genes). The clusters share a region which synthesises the dilactone 56 
core common to all antimycin analogues [5, 6]. Therefore, such gene clusters (originating 57 
from one ancestral cluster) would support the synthesis of different antimicrobial variants [5, 58 
6].  A similar organisation has been identified in the Pseudonocardia spp., which produce 59 
multiple, structurally-similar antimicrobials such as dentigerumycin, gerumycin A, 60 
gerumycin B and gerumycin C, as well as a polyene antifungal, nystatin P1 [4, 7]. The 61 
structural similarity of dentigerumycin, gerumycin A, gerumycin B and gerumycin C, along 62 
with region-specific similarity of two of the three clusters responsible for their synthesis, 63 
suggests they derive from a single ancestral cluster that diversified in response to selection 64 
from antimicrobial-resistant organisms (Figure 1). Several regions of the gene clusters 65 
producing these antimicrobials are flanked by mobile genetic elements (transposases, 66 
integrases, endonucleases), indicating horizontal gene transfers play a role in their 67 
recombination [7]. Such mobile genetic elements could also generate variation within the 68 
gene cluster of one clonal line via transference in and out of the cluster. Similarly, in the 69 
genomes of the Pseudonocardia phylotypes Ps1 and Ps2, novel nystatin P1-like compounds 70 
are encoded by at least 14 biosynthetic gene clusters sharing multiple common genes [8]. 71 
Thus, it seems likely that variability in effectiveness of variants of antimycin produced by 72 
Streptomyces and variants of nystatin and dentigerumycin produced by Pseudonocardia is a 73 
result of constant variation in the gene clusters producing them.  74 
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Escovopsis has evolved countermeasures; in vitro tests suggesting it can develop resistance to 75 
antimicrobials produced by Pseudonocardia, even if the majority of wild populations remain 76 
susceptible to them [9].  Escovopsis is an obligate parasite of the fungus cultivar. This habitat 77 
specificity exerts further selection pressure on the parasite to develop resistance to 78 
antimicrobials produced by the ant-associated bacteria. Furthermore, recent discovery of two 79 
specialised secondary metabolites produced by Escovopsis has offered new insight regarding 80 
antimicrobial-mediated antagonism between parasite and mutualist triumvirate [2]. Both 81 
metabolites inhibit Pseudonocardia growth and one, shearinine D, degrades ants’ Escovopsis 82 
weeding efficiency and, at high concentrations, is lethal to them. It may well be that a similar 83 
pattern of gene cluster evolution might be present in the Escovopsis as described in 84 
Pseudonocardia and Streptomyces.  85 
 86 
Comparing arthropod and human strategies of antimicrobial usage. 87 
If modification of antimicrobial-synthesising gene clusters is amplified in the presence of the 88 
parasite, the diversity of bacterially-synthesised antimicrobials suggests that there is 89 
continuous selection pressure on the bacteria to evolve new variants. They have coevolved 90 
with ants that provide their nutrition and microclimate, so the ants’ continuing existence is 91 
necessary for their survival. In this co-evolutionary arms race, novel bacterial antimicrobial 92 
compounds can be formed via novel gene cluster rearrangement or mutations. Novel 93 
compounds so generated achieve greater or lesser evolutionary success based upon the 94 
Escovopsis strain antimicrobial susceptibility. This mechanism is best explicated by Red 95 
Queen Dynamics [10], by which in the long term, continual evolution of novel antimicrobial 96 
compounds would be encouraged thus preventing sympatric populations of Escovopsis from 97 
acquiring effective antimicrobial resistance. 98 
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In the last decades several models and experimental studies based upon them have been 99 
developed, lending some support to this hypothesis. Mathematical and clinical trials show 100 
that mixing antibiotics results in resistance reduction [11]. Equally, other symbioses of 101 
microorganisms with marine invertebrates, insects and plants, have been shown to rely upon 102 
antibiotic mixtures diversified by interspecies and intraspecies interactions, and constructed 103 
in conjunction with the evolution of biosynthetic gene clusters [12]. The short generation 104 
time of bacteria, rapid recombination of clusters plus horizontal gene transfers [9] are further 105 
amplified by marked potency variations offered by only slight antimicrobial structural 106 
differences [12]. Such mixtures of antibiotics and their derivatives can even reverse antibiotic 107 
resistance via molecular (molecular synergy, antagonism, and suppression) and evolutionary 108 
interactions (cross-resistance and collateral sensitivity) [11]. Thus, whereas cross-resistance 109 
to whole classes of antimicrobial compounds is a feature of clinical antimicrobial 110 
applications, intriguingly, there is little evidence of similar effects limiting efficacy of the 111 
structurally-similar compounds employed by the attines’ symbionts. If cross-resistance is 112 
genuinely absent from this system, it would be of great clinical relevance [11 and references 113 
within]. 114 
When comparing the attine model of natural selection and diversification of antimicrobials to 115 
antimicrobial usage in clinical settings, the contrast is striking. Humans use diverse 116 
antimicrobials, but they are structurally discrete compounds rather than the diverse range of 117 
subtle variants utilised by the ants and their mutualists. The humans’ strategy is also 118 
different; employment of discrete antimicrobials as means of rapid pathogen elimination 119 
rather than one facet of a long-term strategy of progressive inhibition. Finally, and brutally, 120 
the attines have no ethical constraints: not all individuals involved in this arms race must 121 
survive. 122 
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Bearing this in mind, although all anthropogenic antimicrobials have natural blueprints, it 123 
could be that use of structurally-discrete antimicrobials has outlived its usefulness. A new 124 
strategy of in vitro antimicrobial-mediated arms race simulations would permit evaluation of 125 
gene cluster response and emulate an evolutionary approach to antimicrobial generation and 126 
utilisation which has served the attines and their allies for 60 million years. 127 
 128 
BOX 1 129 
Attine ants, allies, enemies and coevolved crypts.  More derived clades of attine ants such 130 
as the leaf-cutting ants (Atta spp. and Acromyrmex spp.) specialise in the cultivation of 131 
Leucoagaricus spp. fungi. In this mutualistic association Leucoagaricus gongylophorus is an 132 
obligate cultivar, and forms the ant colony’s dominant food source [1]. The fungus is 133 
vertically transmitted from colony to colony by the gynes (female reproductive ants) when 134 
they first establish their own colonies. The Leucoagaricus cultivar may be parasitised by 135 
fungi of the genus Escovopsis [2]. In response, the ants house multiple antimicrobial-136 
producing bacteria on their cuticle in coevolved cuticular crypts and specialised exocrine 137 
glands. The two Actinobacteria predominantly associated with the ants are Pseudonocardia 138 
and Streptomyces [4]. Bacteria are also carried by the gynes on their mating flights and 139 
transmitted to offspring colonies [3]. A phylogenetic rooted-tree reconstruction of all known 140 
fungus-growing ants showed that the crypts are specifically evolved to house the 141 
Actinobacteria. They are morphologically different and differently located on the body of 142 
ancient paleo-attines, more basal attine genera and in the later evolved leaf-cutting attines [3].  143 
 144 
 145 
 146 
 147 
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CAPTION 148 
Figure 1. Summary of the interactions among symbionts of Acromyrmex sp. leaf-cutting ants 149 
and microorganisms living in their nest. Ants grow the mutualist (green arrows) fungi 150 
Leucoagaricus spp on cut leaf fragments to provide their sole food source. The parasitic 151 
fungus Escovopsis also feeds off Leucoagaricus (antagonism, red lines). Mutualistic bacteria, 152 
Pseudonocardia (Phylum Actinobacteria) live on the ants, fed via subcuticular glands and, in 153 
return, provide antimicrobial compounds to kill the parasite Escovopsis (antagonism). 154 
Escovopsis counteracts the defensive mutualists by either evolving resistance to the 155 
antimicrobials produced by the Pseudonocardia or via producing antimicrobials such as 156 
melinacidin and shearinine that inhibit Pseudonocardia. The evolution of resistance in 157 
Escovopsis to antimicrobials produced by Pseudonocardia induces selection pressures on the 158 
bacterial gene clusters (dotted pale blue arrow), causing the evolution of antimicrobial gene 159 
clusters harboured in Pseudonocardia, via rearrangement of the gene clusters or via 160 
positively selected mutations in the gene clusters, thus inducing synthesis of novel 161 
antimicrobial compounds.  162 
 163 
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